GSK Keeps Oncology 2.0 Growth Plans On Track

 
• By Mandy Jackson
  
Cancer Cell self destructing cancer cure treatment T-cell lymphocyte killing tumors 3D render
GSK's strategy includes immuno-oncology, synthetic lethality, cell and gene therapy, and epigenetics • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas